| Literature DB >> 31173718 |
Gad D Vatine1, Riccardo Barrile2, Michael J Workman3, Samuel Sances3, Bianca K Barriga3, Matthew Rahnama3, Sonalee Barthakur4, Magdalena Kasendra4, Carolina Lucchesi4, Jordan Kerns4, Norman Wen4, Weston R Spivia5, Zhaohui Chen5, Jennifer Van Eyk5, Clive N Svendsen6.
Abstract
The blood-brain barrier (BBB) tightly regulates the entry of solutes from blood into the brain and is disrupted in several neurological diseases. Using Organ-Chip technology, we created an entirely human BBB-Chip with induced pluripotent stem cell (iPSC)-derived brain microvascular endothelial-like cells (iBMECs), astrocytes, and neurons. The iBMECs formed a tight monolayer that expressed markers specific to brain vasculature. The BBB-Chip exhibited physiologically relevant transendothelial electrical resistance and accurately predicted blood-to-brain permeability of pharmacologics. Upon perfusing the vascular lumen with whole blood, the microengineered capillary wall protected neural cells from plasma-induced toxicity. Patient-derived iPSCs from individuals with neurological diseases predicted disease-specific lack of transporters and disruption of barrier integrity. By combining Organ-Chip technology and human iPSC-derived tissue, we have created a neurovascular unit that recapitulates complex BBB functions, provides a platform for modeling inheritable neurological disorders, and advances drug screening, as well as personalized medicine.Entities:
Keywords: BBB; MCT8; blood-brain barrier; disease model; iPSCs; neural; neurological disease; organ-on-chip; personalized medicine; thyroid
Mesh:
Year: 2019 PMID: 31173718 DOI: 10.1016/j.stem.2019.05.011
Source DB: PubMed Journal: Cell Stem Cell ISSN: 1875-9777 Impact factor: 24.633